These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26758977)

  • 1. The novel RAGE interactor PRAK is associated with autophagy signaling in Alzheimer's disease pathogenesis.
    Kim Y; Kim C; Son SM; Song H; Hong HS; Han SH; Mook-Jung I
    Mol Neurodegener; 2016 Jan; 11():4. PubMed ID: 26758977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAGE mediates Aβ accumulation in a mouse model of Alzheimer's disease via modulation of β- and γ-secretase activity.
    Fang F; Yu Q; Arancio O; Chen D; Gore SS; Yan SS; Yan SF
    Hum Mol Genet; 2018 Mar; 27(6):1002-1014. PubMed ID: 29329433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aβ-induced formation of autophagosomes is mediated by RAGE-CaMKKβ-AMPK signaling.
    Son SM; Jung ES; Shin HJ; Byun J; Mook-Jung I
    Neurobiol Aging; 2012 May; 33(5):1006.e11-23. PubMed ID: 22048125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer's disease.
    Prasad K
    Mol Cell Biochem; 2019 Sep; 459(1-2):95-112. PubMed ID: 31079281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease.
    Fang F; Lue LF; Yan S; Xu H; Luddy JS; Chen D; Walker DG; Stern DM; Yan S; Schmidt AM; Chen JX; Yan SS
    FASEB J; 2010 Apr; 24(4):1043-55. PubMed ID: 19906677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yi-Zhi-Fang-Dai Formula Exerts a Protective Effect on the Injury of Tight Junction Scaffold Proteins in Vitro and in Vivo by Mediating Autophagy through Regulation of the RAGE/CaMKKβ/AMPK/mTOR Pathway.
    Chan Y; Chen W; Chen Y; Lv Z; Wan W; Li Y; Zhang C
    Biol Pharm Bull; 2020; 43(12):1847-1858. PubMed ID: 33268702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aβ-AGE aggravates cognitive deficit in rats via RAGE pathway.
    Chen C; Li XH; Tu Y; Sun HT; Liang HQ; Cheng SX; Zhang S
    Neuroscience; 2014 Jan; 257():1-10. PubMed ID: 24188791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aβ
    Chan Y; Chen W; Wan W; Chen Y; Li Y; Zhang C
    Exp Cell Res; 2018 Aug; 369(2):266-274. PubMed ID: 29856989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced Glycation End Products Modulate Amyloidogenic APP Processing and Tau Phosphorylation: A Mechanistic Link between Glycation and the Development of Alzheimer's Disease.
    Batkulwar K; Godbole R; Banarjee R; Kassaar O; Williams RJ; Kulkarni MJ
    ACS Chem Neurosci; 2018 May; 9(5):988-1000. PubMed ID: 29384651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A specific RAGE-binding peptide biopanning from phage display random peptide library that ameliorates symptoms in amyloid β peptide-mediated neuronal disorder.
    Cai C; Dai X; Zhu Y; Lian M; Xiao F; Dong F; Zhang Q; Huang Y; Zheng Q
    Appl Microbiol Biotechnol; 2016 Jan; 100(2):825-35. PubMed ID: 26496918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer's disease.
    Yan SS; Chen D; Yan S; Guo L; Du H; Chen JX
    Front Biosci (Schol Ed); 2012 Jan; 4(1):240-50. PubMed ID: 22202057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between calcium, amyloid beta and the receptor for advanced glycation endproducts in Alzheimer's disease.
    Leclerc E; Sturchler E; Vetter SW; Heizmann CW
    Rev Neurosci; 2009; 20(2):95-110. PubMed ID: 19774788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAPK, beta-amyloid and synaptic dysfunction: the role of RAGE.
    Origlia N; Arancio O; Domenici L; Yan SS
    Expert Rev Neurother; 2009 Nov; 9(11):1635-45. PubMed ID: 19903023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against RAGE-mediated neuronal cell death by sRAGE-secreting human mesenchymal stem cells in 5xFAD transgenic mouse model.
    Son M; Oh S; Park H; Ahn H; Choi J; Kim H; Lee HS; Lee S; Park HJ; Kim SU; Lee B; Byun K
    Brain Behav Immun; 2017 Nov; 66():347-358. PubMed ID: 28760504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease.
    Sasaki N; Toki S; Chowei H; Saito T; Nakano N; Hayashi Y; Takeuchi M; Makita Z
    Brain Res; 2001 Jan; 888(2):256-262. PubMed ID: 11150482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered intracellular signaling and reduced viability of Alzheimer's disease neuronal cybrids is reproduced by beta-amyloid peptide acting through receptor for advanced glycation end products (RAGE).
    Onyango IG; Tuttle JB; Bennett JP
    Mol Cell Neurosci; 2005 Jun; 29(2):333-43. PubMed ID: 15911356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease.
    Lue LF; Yan SD; Stern DM; Walker DG
    Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):249-66. PubMed ID: 15975028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's disease.
    Chen X; Walker DG; Schmidt AM; Arancio O; Lue LF; Yan SD
    Curr Mol Med; 2007 Dec; 7(8):735-42. PubMed ID: 18331231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel, Multi-Target Natural Drug Candidate, Matrine, Improves Cognitive Deficits in Alzheimer's Disease Transgenic Mice by Inhibiting Aβ Aggregation and Blocking the RAGE/Aβ Axis.
    Cui L; Cai Y; Cheng W; Liu G; Zhao J; Cao H; Tao H; Wang Y; Yin M; Liu T; Liu Y; Huang P; Liu Z; Li K; Zhao B
    Mol Neurobiol; 2017 Apr; 54(3):1939-1952. PubMed ID: 26899576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAGE and Alzheimer's disease: a progression factor for amyloid-beta-induced cellular perturbation?
    Yan SD; Bierhaus A; Nawroth PP; Stern DM
    J Alzheimers Dis; 2009; 16(4):833-43. PubMed ID: 19387116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.